These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19401286)

  • 21. Coronary artery disease and the use of stents.
    Am Fam Physician; 2009 Dec; 80(11):1252-3. PubMed ID: 20020554
    [No Abstract]   [Full Text] [Related]  

  • 22. The euros and sense of stents: do we get value for money?
    Annemans L
    J Cardiovasc Med (Hagerstown); 2011 Dec; 12(12):878-82. PubMed ID: 22025203
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.
    Bittl JA
    J Am Coll Cardiol; 2009 Mar; 53(11):929-30. PubMed ID: 19281921
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of efficacy and cost-effectiveness of drug-eluting stents.
    Lyratzopoulos G
    Eur Heart J; 2006 Dec; 27(24):3075-6; author reply 3076. PubMed ID: 17127710
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
    Silber S; Borggrefe M; Böhm M; Hoffmeister HM; Dietz R; Ertl G; Heusch G
    Clin Res Cardiol; 2008 Aug; 97(8):548-63. PubMed ID: 18726643
    [No Abstract]   [Full Text] [Related]  

  • 26. The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem?
    Mukherjee D
    Am Heart J; 2009 Oct; 158(4):506-8. PubMed ID: 19781406
    [No Abstract]   [Full Text] [Related]  

  • 27. Xience V everolimus-eluting coronary stent.
    Kukreja N; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome observations with drug-eluting stents.
    Steffenino G; Olivari Z
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):110-2. PubMed ID: 18192800
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting stents.
    Cohen DJ; Bakhai A
    CMAJ; 2007 May; 176(11):1612. PubMed ID: 17515592
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-eluting stents.
    Rinfret S; Schampaert E
    CMAJ; 2007 May; 176(11):1611-2. PubMed ID: 17515589
    [No Abstract]   [Full Text] [Related]  

  • 33. LM stenting--a comrade (sic . . . a friend !) in Arm's viewpoint.
    Yadava OP
    Indian Heart J; 2008; 60(3):179-87. PubMed ID: 19240303
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-eluting stents are safe.
    Garg S; Serruys P
    Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
    [No Abstract]   [Full Text] [Related]  

  • 35. Late in-stent restenosis in a patient with drug-eluting stent.
    Sultan FA; Kazmi K; Dhakam S; Quraishi AU
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case where the principle of "one question, one answer" may work better.
    Tada T; Byrne RA; Kastrati A
    Am Heart J; 2012 Feb; 163(2):133-5. PubMed ID: 22305827
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular device technology and health care cost.
    Dean LS
    Arch Intern Med; 2011 Oct; 171(18):1689; author's reply 1689. PubMed ID: 21987207
    [No Abstract]   [Full Text] [Related]  

  • 38. Stent choice and the hidden consequences of cost savings.
    Cavender MA; Ellis SG
    Nat Rev Cardiol; 2012 Oct; 9(10):559-60. PubMed ID: 22922596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of drug eluting stents to clinical practice in Japan: are we going in the right direction?
    Aoki J
    Circ J; 2010 Aug; 74(8):1532-3. PubMed ID: 20647637
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-eluting stents: a study of international practice.
    Austin D; Oldroyd KG; Holmes DR; Rihal CS; Galbraith PD; Ghali WA; Legrand V; Taeymans Y; McConnachie A; Pell JP; ; ; ;
    Am Heart J; 2009 Oct; 158(4):576-84. PubMed ID: 19781417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.